21 CFR § 524.1446 Ophthalmic and Topical Dosage Form New Animal Drugs

§ 524.1446 Milbemycin otic solution.

Current through Sep 8, 2026 · Read all of Part 524

(a) Specifications. Each tube contains 0.25 milliliter of a 0.1 percent solution of milbemycin oxime.

(b) Sponsor. See No. 058198 in § 510.600(c) of this chapter.

(c) Conditions of use—(1) Amount. One tube administered topically into each external ear canal.

(2) Indications for use. For the treatment of ear mite (Otodectes cynotis) infestations in cats and kittens 4 weeks of age and older. Effectiveness is maintained throughout the life cycle of the ear mite.

(3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

[65 FR 13905, Mar. 15, 2000, as amended at 66 FR 13849, Mar. 8, 2001]

← § 524.1445 Miconazole, polymixin B, and prednisolone suspension.§ 524.1448 Mirtazapine transdermal ointment. →